| 1 | [SID856728] | Active | IC50 | 5.92 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624317, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | IC50 | 5.92 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624317 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 2 | [SID856728] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID856728] | Active | IC50 | 41.1 | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 [AID651709, Type: confirmatory] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | IC50 | 41.1 [uM] | | BioAssay | Dose response confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay - Set 2 | | AID | 651709 | | BioAssay type | confirmatory | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 4 | [SID856728] | Active | | | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624309, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624309 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 5 | [SID856728] | Active | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 6 | [SID856728] | Active | | | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay [AID463212, Type: screening] | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay | | AID | 463212 | | BioAssay type | screening | | Target | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] | | PubMed | | | Data Table |  |
|
| 7 | [SID856728] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 8 | [SID856728] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 9 | [SID856728] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 10 | [SID856728] | Active | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 11 | [SID856728] | Active | | | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID624416, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 | | AID | 624416 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 12 | [SID856728] | Active | | | Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput assay to identify small molecules that bind to the control antibody, PGV04, which binds to a site on the HIV envelope different from the PG9 binding site [AID651604, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput assay to identify small molecules that bind to the control antibody, PGV04, which binds to a site on the HIV envelope different from the PG9 binding site | | AID | 651604 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 13 | [SID856728] | Active | | | TRFRET-based biochemical high throughput confirmation assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID651571, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | TRFRET-based biochemical high throughput confirmation assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 | | AID | 651571 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 14 | [SID856728] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 15 | [SID856728] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 16 | [SID856728] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators [AID639, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators | | AID | 639 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 17 | [SID856728] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators [AID639, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators | | AID | 639 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 18 | [SID856728] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators [AID639, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators | | AID | 639 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 19 | [SID856728] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators [AID639, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators | | AID | 639 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 20 | [SID856728] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 21 | [SID856728] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 22 | [SID856728] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 23 | [SID856728] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 24 | [SID856728] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 25 | [SID856728] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 26 | [SID856728] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 27 | [SID856728] | Active | | | Primary Antimicrobial Assay for E. coli BW25113 ∆tolC::kan Protocol for 384-well HTS [AID573, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Primary Antimicrobial Assay for E. coli BW25113 ∆tolC::kan Protocol for 384-well HTS | | AID | 573 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID856728] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID856728] | Active | | | Screening for Modulators of Post-Golgi Transport, Control Strain [AID738, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Screening for Modulators of Post-Golgi Transport, Control Strain | | AID | 738 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID856728] | Active | | | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen [AID1362, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen | | AID | 1362 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID856728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 32 | [SID856728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 33 | [SID856728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 34 | [SID856728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 35 | [SID856728] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID856728] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID856728] | Inactive | Potency | 3.1623 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 38 | [SID856728] | Inactive | Potency | 3.1623 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 39 | [SID856728] | Inactive | Potency | 28.1838 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 40 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 41 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 42 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 43 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 44 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1). [AID588819, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1). | | AID | 588819 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 45 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1). [AID588819, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1). | | AID | 588819 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 46 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 47 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 48 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 49 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 50 | [SID856728] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 856728 | | CID | 54679933 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|